Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 91495

8 recalled-product records grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
February 01, 2023
Product types
Device
Classifications
Class II
Statuses
Ongoing
Recalling firm wording
Becton Dickinson & Company

Dossier provenance

Source snapshots represented here

  • openFDA Device Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.
  • openFDA Device Recall event_date_initiated coverage June 01, 1997–June 30, 2026

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

8 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

device · product 1 of 8

BD Ultra-Fine Insulin Syringe 0.5mL, 6mm, 31G - Insulin Syringes are designed for administering insulin in the treatment of diabetes mellitus. Catalog Number: 326679

Z-1237-2023
Recall number
Z-1237-2023
Initiated
February 01, 2023
Classification
Class II
Status
Ongoing
Quantity
45, 000 units

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Nonsterile syringe potentially exposing the patient to pathogenic microorganisms and a risk of local infection.

These labels are deterministic app interpretations, not FDA categories.

Official device-enrichment evidence · Unknown

An exact joined enrichment record exists, but none supplies supported root-cause wording. This is not an FDA finding of an unknown cause.

Compare all device evidence states

Inspect official wording and provenance

Reason for recall

Nonsterile syringe potentially exposing the patient to pathogenic microorganisms and a risk of local infection.

Code information

UDI_DI: N/A Lot Number: 2164338 Exp Date: 20270831

Distribution pattern

Worldwide distribution - US Nationwide and the countries of Chile, Colombia, Dominican Republic, Bahamas, Panama, Peru, Mexico, El Salvador, Mexico, Malaysia, Philippines, Vietnam, Hong Kong, Taiwan, Thailand, Canada.

device · product 2 of 8

BD Insulin Syringes with the BD Micro-Fine TM IV Needle 1ml, 12.7mm, 28G Single Unit Scale. Insulin Syringes are designed for administering insulin in the treatment of diabetes mellitus. Catalog Number: 329420

Z-1238-2023
Recall number
Z-1238-2023
Initiated
February 01, 2023
Classification
Class II
Status
Ongoing
Quantity
961,000 units

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Nonsterile syringe potentially exposing the patient to pathogenic microorganisms and a risk of local infection.

These labels are deterministic app interpretations, not FDA categories.

Official device-enrichment evidence · Unknown

An exact joined enrichment record exists, but none supplies supported root-cause wording. This is not an FDA finding of an unknown cause.

Compare all device evidence states

Inspect official wording and provenance

Reason for recall

Nonsterile syringe potentially exposing the patient to pathogenic microorganisms and a risk of local infection.

Code information

GTIN: (01) 00382903294206 Lot Number: 2038204 Exp. Date: 20270430

Distribution pattern

Worldwide distribution - US Nationwide and the countries of Chile, Colombia, Dominican Republic, Bahamas, Panama, Peru, Mexico, El Salvador, Mexico, Malaysia, Philippines, Vietnam, Hong Kong, Taiwan, Thailand, Canada.

device · product 3 of 8

BD Insulin Syringes with the BD Micro-Fine IV Needle 1 ml, 12. 7mm, 28G Two Unit Scale- Insulin Syringes are designed for administering insulin in the treatment of diabetes mellitus. Catalog Number: 329424

Z-1239-2023
Recall number
Z-1239-2023
Initiated
February 01, 2023
Classification
Class II
Status
Ongoing
Quantity
1,921,000 units

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Nonsterile syringe potentially exposing the patient to pathogenic microorganisms and a risk of local infection.

These labels are deterministic app interpretations, not FDA categories.

Official device-enrichment evidence · Unknown

An exact joined enrichment record exists, but none supplies supported root-cause wording. This is not an FDA finding of an unknown cause.

Compare all device evidence states

Inspect official wording and provenance

Reason for recall

Nonsterile syringe potentially exposing the patient to pathogenic microorganisms and a risk of local infection.

Code information

GTIN : (01) 00382903294244 Lot Number: 2024074 Exp. Date: 2024074; Lot Number: 2045195 Exp. Date: 20270430

Distribution pattern

Worldwide distribution - US Nationwide and the countries of Chile, Colombia, Dominican Republic, Bahamas, Panama, Peru, Mexico, El Salvador, Mexico, Malaysia, Philippines, Vietnam, Hong Kong, Taiwan, Thailand, Canada.

device · product 4 of 8

BD Ultra-Fine Insulin Syringe 0.5mL, 8mm, 31G-Insulin Syringes are designed for administering insulin in the treatment of diabetes mellitus. Catalog Number: 326713

Z-1240-2023
Recall number
Z-1240-2023
Initiated
February 01, 2023
Classification
Class II
Status
Ongoing
Quantity
1,129,000 units

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Nonsterile syringe potentially exposing the patient to pathogenic microorganisms and a risk of local infection.

These labels are deterministic app interpretations, not FDA categories.

Official device-enrichment evidence · Unknown

An exact joined enrichment record exists, but none supplies supported root-cause wording. This is not an FDA finding of an unknown cause.

Compare all device evidence states

Inspect official wording and provenance

Reason for recall

Nonsterile syringe potentially exposing the patient to pathogenic microorganisms and a risk of local infection.

Code information

GTIN: N/A Lot Number: 2038580, Exp. Date: 20270531; Lot Number: 2063298, Exp. Date: 20270531; Lot Number: 2137904, Exp. Date: 20270731

Distribution pattern

Worldwide distribution - US Nationwide and the countries of Chile, Colombia, Dominican Republic, Bahamas, Panama, Peru, Mexico, El Salvador, Mexico, Malaysia, Philippines, Vietnam, Hong Kong, Taiwan, Thailand, Canada.

device · product 5 of 8

BD Ultra-Fine Insulin Syringe 1mL, 6mm, 31G-Insulin Syringes are designed for administering insulin in the treatment of diabetes mellitus. Catalog Number: 326678

Z-1241-2023
Recall number
Z-1241-2023
Initiated
February 01, 2023
Classification
Class II
Status
Ongoing
Quantity
1,168,000 units

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Nonsterile syringe potentially exposing the patient to pathogenic microorganisms and a risk of local infection.

These labels are deterministic app interpretations, not FDA categories.

Official device-enrichment evidence · Unknown

An exact joined enrichment record exists, but none supplies supported root-cause wording. This is not an FDA finding of an unknown cause.

Compare all device evidence states

Inspect official wording and provenance

Reason for recall

Nonsterile syringe potentially exposing the patient to pathogenic microorganisms and a risk of local infection.

Code information

GTIN: N/A Lot Number: 2045201, Exp. Date: 20270430; Lot Number: 2073801, Exp. Date: 20270531

Distribution pattern

Worldwide distribution - US Nationwide and the countries of Chile, Colombia, Dominican Republic, Bahamas, Panama, Peru, Mexico, El Salvador, Mexico, Malaysia, Philippines, Vietnam, Hong Kong, Taiwan, Thailand, Canada.

device · product 6 of 8

BD Insulin Syringes with the BD Micro-Fine IV Needle 0.5ml, 12.7mm, 28G Single Unit Scale-Insulin Syringes are designed for administering insulin in the treatment of diabetes mellitus. Catalog Number: 329461

Z-1242-2023
Recall number
Z-1242-2023
Initiated
February 01, 2023
Classification
Class II
Status
Ongoing
Quantity
686,500 units

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Nonsterile syringe potentially exposing the patient to pathogenic microorganisms and a risk of local infection.

These labels are deterministic app interpretations, not FDA categories.

Official device-enrichment evidence · Unknown

An exact joined enrichment record exists, but none supplies supported root-cause wording. This is not an FDA finding of an unknown cause.

Compare all device evidence states

Inspect official wording and provenance

Reason for recall

Nonsterile syringe potentially exposing the patient to pathogenic microorganisms and a risk of local infection.

Code information

GTIN: (01) 00382903294619 Lot Number: 2031528, Exp. Date: 20270430

Distribution pattern

Worldwide distribution - US Nationwide and the countries of Chile, Colombia, Dominican Republic, Bahamas, Panama, Peru, Mexico, El Salvador, Mexico, Malaysia, Philippines, Vietnam, Hong Kong, Taiwan, Thailand, Canada.

device · product 7 of 8

BD Ultra-Fine Insulin Syringe 1mL, 12.7mm, 29G-Insulin Syringes are designed for administering insulin in the treatment of diabetes mellitus. Catalog Number: 326719

Z-1243-2023
Recall number
Z-1243-2023
Initiated
February 01, 2023
Classification
Class II
Status
Ongoing
Quantity
80,500 units

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Nonsterile syringe potentially exposing the patient to pathogenic microorganisms and a risk of local infection.

These labels are deterministic app interpretations, not FDA categories.

Official device-enrichment evidence · Unknown

An exact joined enrichment record exists, but none supplies supported root-cause wording. This is not an FDA finding of an unknown cause.

Compare all device evidence states

Inspect official wording and provenance

Reason for recall

Nonsterile syringe potentially exposing the patient to pathogenic microorganisms and a risk of local infection.

Code information

GTIN: N/A Lot Number: 2031581, Exp. Date: 2031581

Distribution pattern

Worldwide distribution - US Nationwide and the countries of Chile, Colombia, Dominican Republic, Bahamas, Panama, Peru, Mexico, El Salvador, Mexico, Malaysia, Philippines, Vietnam, Hong Kong, Taiwan, Thailand, Canada.

device · product 8 of 8

BD Ultra-Fine II Insulin Syringe 0.5mL, 8mm, 30G-Insulin Syringes are designed for administering insulin in the treatment of diabetes mellitus. Catalog Number: 326725

Z-1244-2023
Recall number
Z-1244-2023
Initiated
February 01, 2023
Classification
Class II
Status
Ongoing
Quantity
1,472,400 units

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Nonsterile syringe potentially exposing the patient to pathogenic microorganisms and a risk of local infection.

These labels are deterministic app interpretations, not FDA categories.

Official device-enrichment evidence · Unknown

An exact joined enrichment record exists, but none supplies supported root-cause wording. This is not an FDA finding of an unknown cause.

Compare all device evidence states

Inspect official wording and provenance

Reason for recall

Nonsterile syringe potentially exposing the patient to pathogenic microorganisms and a risk of local infection.

Code information

GTIN: N/A Lot Number: 2010670, Exp. Date:2031581 Lot Number: 2052365, Exp. Date:20270531

Distribution pattern

Worldwide distribution - US Nationwide and the countries of Chile, Colombia, Dominican Republic, Bahamas, Panama, Peru, Mexico, El Salvador, Mexico, Malaysia, Philippines, Vietnam, Hong Kong, Taiwan, Thailand, Canada.